Peter Choyke

3.9k total citations
20 papers, 649 citations indexed

About

Peter Choyke is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Peter Choyke has authored 20 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Peter Choyke's work include Cancer, Hypoxia, and Metabolism (6 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Peter Choyke is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Peter Choyke collaborates with scholars based in United States, Norway and Cameroon. Peter Choyke's co-authors include Seth M. Steinberg, Barış Türkbey, Shivaani Kummar, James H. Doroshow, Sook Ryun Park, Alice P. Chen, Giovanni Melillo, Robert J. Kinders, Woondong Jeong and Annamaria Rapisarda and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Peter Choyke

20 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Choyke United States	12	277	272	212	207	133	20	649
Maria Merino United States	11	153 0.6×	208 0.8×	243 1.1×	200 1.0×	136 1.0×	12	592
Kwang‐Sun Suh South Korea	15	235 0.8×	235 0.9×	183 0.9×	105 0.5×	105 0.8×	55	802
Maura O’Neil United States	16	199 0.7×	275 1.0×	245 1.2×	137 0.7×	65 0.5×	46	795
Emma Guagnellini Italy	12	332 1.2×	186 0.7×	236 1.1×	99 0.5×	93 0.7×	21	693
Lichen Teng China	17	156 0.6×	270 1.0×	109 0.5×	79 0.4×	95 0.7×	63	1.0k
Maki Tanioka Japan	17	166 0.6×	261 1.0×	335 1.6×	124 0.6×	111 0.8×	76	841
Yongfeng Ding China	18	150 0.5×	305 1.1×	409 1.9×	105 0.5×	213 1.6×	51	944
Vilmos Adleff Hungary	15	353 1.3×	295 1.1×	282 1.3×	86 0.4×	171 1.3×	32	716
Josefina Móra Spain	17	293 1.1×	279 1.0×	449 2.1×	355 1.7×	191 1.4×	58	949
Daizo Oka Japan	13	129 0.5×	255 0.9×	129 0.6×	128 0.6×	172 1.3×	23	567

Countries citing papers authored by Peter Choyke

Since Specialization

Citations

This map shows the geographic impact of Peter Choyke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Choyke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Choyke more than expected).

Fields of papers citing papers by Peter Choyke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Choyke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Choyke. The network helps show where Peter Choyke may publish in the future.

Co-authorship network of co-authors of Peter Choyke

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Choyke. A scholar is included among the top collaborators of Peter Choyke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Choyke. Peter Choyke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Furusawa, Aki, Motofumi Suzuki, Makoto Kano, et al.. (2025). EpCAM-targeted near-infrared photoimmunotherapy (NIR-PIT) for the treatment of breast cancer. Annals of Medicine. 57(1). 2540599–2540599. 1 indexed citations

Patkar, Sushant, Rachel Chernet, Prashanth Ashok Kumar, et al.. (2024). Predicting the tumor microenvironment composition and immunotherapy response in non-small cell lung cancer from digital histopathology images. npj Precision Oncology. 8(1). 280–280. 7 indexed citations

Patel, Krishnan R., Lindsay Rowe, Holly Ning, et al.. (2022). A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy. Advances in Radiation Oncology. 7(6). 101024–101024. 2 indexed citations

Wei, Ling, Elaine M. Jagoda, Karen Wong, et al.. (2019). Development of 89Zr-Avelumab for Clinical Studies. 60. 1060–1060. 2 indexed citations

Imani, Farhad, Amir Tahmasebi, Jin Tae Kwak, et al.. (2015). Augmenting MRI–transrectal ultrasound-guided prostate biopsy with temporal ultrasound data: a clinical feasibility study. International Journal of Computer Assisted Radiology and Surgery. 10(6). 727–735. 9 indexed citations

Schuster, David M., Cristina Nanni, Stefano Fanti, et al.. (2014). Anti-1-Amino-3-F-18-Fluorocyclobutane-1-Carboxylic Acid: Physiologic Uptake Patterns, Incidental Findings, and Variants That May Simulate Disease. Journal of Nuclear Medicine & Radiation Therapy. 55(12). 1986–1992. 20 indexed citations

Srinivasan, Ramprasad, Lambros Stamatakis, Eric A. Singer, et al.. (2014). 5 Mechanism based targeted therapy for hereditary leiomyomatosis and renal cell cancer (HLRCC) and sporadic papillary renal cell carcinoma: interim results from a phase 2 study of bevacizumab and erlotinib. European Journal of Cancer. 50. 8–8. 27 indexed citations

Jeong, Woondong, Sook Ryun Park, Annamaria Rapisarda, et al.. (2013). Weekly EZN-2208 (PEGylated SN-38) in combination with bevacizumab in patients with refractory solid tumors. Investigational New Drugs. 32(2). 340–346. 23 indexed citations

Jeong, Woondong, Annamaria Rapisarda, Sook Ryun Park, et al.. (2013). Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors. Cancer Chemotherapy and Pharmacology. 73(2). 343–348. 128 indexed citations

10.

Azad, Nilofer S., Minshu Yu, Ben Davidson, et al.. (2013). Translational Predictive Biomarker Analysis of the Phase 1b Sorafenib and Bevacizumab Study Expansion Cohort. Molecular & Cellular Proteomics. 12(6). 1621–1631. 10 indexed citations

11.

Greene, Mark H., Christian P. Kratz, Christine M. Mueller, et al.. (2010). Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype. Endocrine Related Cancer. 17(2). R109–R121. 73 indexed citations

12.

Kummar, Shivaani, Deborah Allen, Barış Türkbey, et al.. (2008). A phase II study of multikinase inhibitor sorafenib in patients with relapsed non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 26(15_suppl). 19084–19084. 19 indexed citations

13.

Kramer, Joan L., Christine M. Mueller, Susan Pfeiffer, et al.. (2007). A possible new syndrome with growth-hormone secreting pituitary adenoma, colonic polyposis, lipomatosis, lentigines and renal carcinoma in association with familial testicular germ cell malignancy: A case report. Journal of Medical Case Reports. 1(1). 9–9. 8 indexed citations

14.

Bates, Susan E., Susan Bakke, Min H. Kang, et al.. (2004). A Phase I/II Study of Infusional Vinblastine with the P-Glycoprotein Antagonist Valspodar (PSC 833) in Renal Cell Carcinoma. Clinical Cancer Research. 10(14). 4724–4733. 56 indexed citations

15.

Abraham, Jame, Susan Bakke, Ann Rutt, et al.. (2002). A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma. Cancer. 94(9). 2333–2343. 82 indexed citations

16.

Alexander, H. Richard, et al.. (2002). Role of preoperative localization and intraoperative localization maneuvers including intraoperative PTH assay determination for patients with persistent or recurrent hyperparathyroidism.. PubMed. 17 Suppl 2. N133–40. 23 indexed citations

17.

Bates, Susan E., Min H. Kang, Beverly Meadows, et al.. (2001). A Phase I study of infusional vinblastine in combination with the p-glycoprotein antagonist PSC 833 (valspodar). Cancer. 92(6). 1577–1590. 63 indexed citations

18.

Ludlow, Christy L., et al.. (1999). Three‐Dimensional Changes in the Upper Airway During Neuromuscular Stimulation of Laryngeal Muscles. Artificial Organs. 23(5). 463–465. 5 indexed citations

19.

Stolle, Catherine A., G.M. Glenn, Berton Zbar, et al.. (1998). Improved detection of germline mutations in the von Hippel‐Lindau disease tumor suppressor gene. Human Mutation. 12(6). 417–423. 31 indexed citations

20.

Glenn, G.M., Peter Choyke, W. Marston Linehan, et al.. (1991). Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus. Human Genetics. 87(2). 207–210. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact